no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Acquired Resistance Is Oncogene and Drug Agnostic
|
Doebele, Robert C. |
|
|
36 |
4 |
p. 347-349 |
article |
2 |
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
|
Burr, Marian L. |
|
|
36 |
4 |
p. 385-401.e8 |
article |
3 |
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants
|
Eide, Christopher A. |
|
|
36 |
4 |
p. 431-443.e5 |
article |
4 |
Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization
|
Gomes, Ana P. |
|
|
36 |
4 |
p. 402-417.e13 |
article |
5 |
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies
|
Guièze, Romain |
|
|
36 |
4 |
p. 369-384.e13 |
article |
6 |
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity
|
Robichaux, Jacqulyne P. |
|
|
36 |
4 |
p. 444-457.e7 |
article |
7 |
PRC2 Plays Red Light, Green Light with MHC-I and CD8+ T Cells
|
Whetstine, Johnathan R. |
|
|
36 |
4 |
p. 343-345 |
article |
8 |
Thrown for a Loop: Awakening BORIS to Evade ALK Inhibition Therapy
|
Berko, Esther R. |
|
|
36 |
4 |
p. 345-347 |
article |
9 |
Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA
|
van der Pol, Ymke |
|
|
36 |
4 |
p. 350-368 |
article |
10 |
Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
|
Ma, Lichun |
|
|
36 |
4 |
p. 418-430.e6 |
article |
11 |
Venetoclax in Lymphoid Malignancies: New Insights, More to Learn
|
Thijssen, Rachel |
|
|
36 |
4 |
p. 341-343 |
article |